在慢性病中评估骨质疏松症:骨质量和骨质量都很重要
Maria J Lloret1,2, Maria Fusaro3,4, Hanne S Jørgensen5,6
1Nephrology Department, Fundació Puigvert, Cartagena 340-350, 08025 Barcelona, Spain.
Journal of clinical medicine
|February 24, 2024
概括
骨强度取决于数量和质量. 慢性病 (CKD) 对两者都有影响,需要超越骨矿物质密度 (BMD) 的先进评估方法来准确预测骨折风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 整形外科 整形外科 整形外科
- 生物医学工程 生物医学工程
背景情况:
- 骨强度依赖于骨质量 (骨矿物质密度) 和骨质量.
- 骨质量包括基质组成,原结构,微型结构和矿化,影响骨的机械性能和骨折抵抗力.
- 慢性病 (CKD) 复杂化骨质疏松症通过结合传统的风险因素与CKD特定的问题,如尿素毒素和骨,影响骨质.
研究的目的:
- 探索影响CKD相关骨质疏松症骨质量和质量的因素.
- 在CKD的背景下,审查目前评估骨质量的技术.
- 要突出仅仅依靠骨矿物密度 (BMD) 来评估CKD患者骨折风险的局限性.
主要方法:
- 审查有关CKD骨质和骨质量的现有文献.
- 讨论双能X射线吸收计 (DXA) 用于测量 BMD 和预测 CKD 中的骨折风险.
- 探索骨质量评估的先进技术,包括骨活检,高分辨率外围定量计算断层扫描 (HR-pQCT) 和冲击微印记.
主要成果:
- 在CKD患者中,即使不符合密度计骨质疏松症标准,骨折也可能发生.
- 特定于CKD的因素显著影响骨质量,而不依赖于骨质量.
- 目前的骨质评估方法往往是昂贵或侵入性的,限制了临床应用.
结论:
- 在CKD中进行全面的骨折风险评估需要评估骨的数量和质量.
- 评估骨质量的先进技术正在出现,但临床实施仍然是一个挑战.
- 在CKD管理中需要进一步的研究和开发,以获得可访问和可靠的骨质评估工具.
关键词:
DXA DXA 是一个骨矿物质密度 骨矿物质密度骨质 骨质的质量 骨质的质量慢性脏疾病 慢性脏疾病密度测量 (Densitometry) 是一种密度测量方法.骨折 骨折 骨折 骨折 在骨质疏松症是一种骨质疏松症.更多相关视频
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
2.0K
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
8.2K
相关概念视频
01:29Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
01:31Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
01:17Factors Affecting Renal Clearance: Renal Impairment
94
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
94
01:40Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
01:11Renal Failure: Dose Adjustments
89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89
01:25Role of Vitamins in Maintaining Bone Health
3.3K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.3K